APA引文

Taghizadeh, H., Marhold, M., Tomasich, E., Udovica, S., Merchant, A., & Krainer, M. (2019). Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives. Oncoimmunology.

Citação norma Chicago

Taghizadeh, H., M. Marhold, E. Tomasich, S. Udovica, A. Merchant, and M. Krainer. "Immune Checkpoint Inhibitors in MCRPC - Rationales, Challenges and Perspectives." Oncoimmunology 2019.

MLA引文

Taghizadeh, H., et al. "Immune Checkpoint Inhibitors in MCRPC - Rationales, Challenges and Perspectives." Oncoimmunology 2019.